Context: Dyslipidemia coexists with hyperglycemia. However, little is known about the ethnic differences in lipid profiles at comparable glucose tolerance status.
D
yslipidemia coexists not only with diabetes but also with impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) (1, 2) . A pattern of atherogenic dyslipidemia, consisting of high triglycerides (TGs) and small, dense, low-density lipoprotein cholesterol (LDL-C) and low high-density lipoprotein cholesterol (HDL-C), is closely linked to the progress of insulin resistance and atherosclerosis in the hyperglycemic state (3) . It has already been shown that the prevalence of lipid or glucose abnormality differs between ethnic groups. A high prevalence of atherogenic dyslipidemia (4, 5) or diabetes (6) has been reported in Asian Indians compared with whites. However, little is known about the ethnic differences in lipid profiles at comparable glucose tolerance status. This study based on the collaborative data analysis of the DECODE (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe) and DECODA (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia) studies of Europeans and Asians addresses this issue.
Subjects and Methods

Study population
The study population and the recruitment of participants have been described in detail in previous DECODE/DECODA publications (7) (8) (9) (10) . Briefly, researchers who had carried out populationbased or large occupational epidemiological studies on diabetes in Europe or Asia, using a standard 2-h 75-g oral glucose tolerance test, were invited to participate. Individual data on fasting plasma glucose (FPG) and 2-h plasma glucose (2hPG) concentrations as well as blood total cholesterol (TC), HDL-C, and TG and a number of other variables were sent to the Diabetes Prevention Unit of the National Institute for Health and Welfare in Helsinki, Finland, for collaborative data analysis. The Ethics Committee of the National Public Health Institute had approved the data analysis plans for both the DECODE and the DECODA studies. The inclusion criteria for the current data analysis were: 1) participants aged 25 to 74 yr; 2) baseline examination performed after 1980; and 3) data on TC, HDL-C, TG, FPG, 2hPG, and body mass index (BMI) available. A total of 52,355 subjects (24,760 men and 27,595 women with a mean age of 50 yr) from 31 (18 in DECODE and 13 in DECODA) study cohorts of 12 countries, including Asian Indian, Chinese, European, Japanese, and Mauritian Indian subjects, met the inclusion criteria and were included in the data analysis ( Table  1 ). The Chinese were further divided into Qingdao and Hong Kong subgroups, and the Europeans into southern (Italy, Republic of Cyprus, and Spain) and central and northern (C&N) Europeans (Finland, Poland, Sweden, The Netherlands, and the United Kingdom) considering varying geographic locations, living environments, lifestyle habits, and socioeconomic status that may have a complex impact on metabolic characteristics.
Measurements
In all cohorts, blood samples were collected after overnight fasting for the measurements of plasma glucose and lipids. Plasma glucose was measured in each of the studies with an oxidase or dehydrogenase method. Detailed information on lipid and lipoprotein assays in each study is shown in Supplemental Table 1 (published as supplemental data on The Endocrine Society's Journals Online web site at http://jcem.endojournals.org). Briefly, TC and TG were determined using enzymatic techniques (11) (12) (13) in all laboratories, and HDL-C was measured enzymatically after a precipitation of apolipoprotein B-containing lipoproteins with established methods (14) in most of the laboratories, except in the Qingdao 2006 study from China, the Funagata study from Japan, and two Indian studies in India applying direct method for HDL-C assay (Table 1) . LDL-C was calculated among individuals with a TG value of less than 4.5 mmol/liter (n ϭ 51,521) using the Friedewald formula (15) as follows: LDL-C (in mmol/liter) ϭ TC Ϫ HDL-C Ϫ (0.45‫ء‬TG). Individuals with a TG of at least 4.5 mmol/liter (n ϭ 834) were excluded from the analysis related to the LDL-C. The Mauritian samples were analyzed locally, with quality control analyzed in Newcastle, United Kingdom, as previously described (16, 17) .
According to the World Health Organization 1999 criteria (18), a person with a prior history of diabetes was classified with previously diagnosed diabetes regardless of the glucose levels, and those with no history of diabetes were classified based on both FPG and 2hPG levels. Previously undiagnosed diabetes was defined as an FPG of at least 7.0 mmol/liter and/or 2hPG of at least 11.1 mmol/ liter; IFG and/or IGT, i.e. prediabetes, was defined as FPG of 6.1-6.9 mmol/liter or 2hPG of 7.8 -11.0 mmol/liter; and normal fasting glucose (NFG) and normal glucose tolerance (NGT), i.e. normoglycemia, were defined as FPG less than 6.1 mmol/liter and 2hPG less than 7.8 mmol/liter, respectively. According to the International Diabetes Federation criteria for the metabolic syndrome (19) , elevated TG was defined as TG of at least 1.7 mmol/liter; reduced HDL-C was defined as HDL-C less than 1.03 mmol/liter for men and less than 1.29 mmol/liter for women. High LDL-C was defined as LDL-C of at least 3.0 mmol/liter according to the European guidelines on cardiovascular disease (CVD) prevention (20) .
Statistical analysis
Analysis of covariance was used to estimate the ethnic-and sexspecific mean concentration of each lipid variable with 95% confidence interval (CI), adjusted for age, study cohort, and BMI. Within each glucose category, pairwise comparisons between ethnic groups were made with Bonferroni method to adjust for multiple comparisons. Logarithmic transformation was used for TG due to its skewed distribution. Logistic regression analysis was used to estimate the odds of having low HDL-C, high TG, or high LDL-C for each ethnic group as compared with that for C&N Europeans (reference group) at a given glucose category, adjusted for age, study cohort, BMI, systolic blood pressure, and smoking status. Waist was not adjusted in the multivariate analysis because it was not available for every study. The proportions of individuals with different dyslipidemia were compared between ethnic groups using the 2 test. All statistical analyses were performed using SPSS 15.0 for Windows (SPSS Inc., Chicago, IL).
Results
Lipid distributions in relation to ethnicity and glucose categories
Age-, study cohort-, and BMI-adjusted mean TC, LDL-C, and TG increased, whereas the mean HDL-C decreased with more pronounced glucose intolerance in most of the ethnic groups in individuals without a prior history of diabetes (Fig.  1, A-H) . Subjects with undiagnosed diabetes, however, had a worse lipid profile than those with known disease.
Within individuals with normoglycemia, mean lipid and lipoprotein concentrations differed among the ethnic groups. The Europeans had the highest TC (Fig. 1, A and  B ; P Ͻ 0.05) and LDL-C (Fig. 1, C and D ; P Ͻ 0.05), whereas Qingdao Chinese had the highest HDL-C levels ( Fig. 1 , E and F; P Ͻ 0.05) among all ethnic groups. In contrast, Asian Indians had the lowest TC (Fig. 1 , A and B; P Ͻ 0.05), LDL-C (Fig. 1 , C and D; P Ͻ 0.05), and HDL-C (Fig. 1 , E and F; P Ͻ 0.05), but the highest TG (Fig.  1 , G and H; P Ͻ 0.05) among the ethnic groups. These ethnic differences were consistently found in all glucose categories.
Dyslipidemia in relation to ethnicity controlling for glucose levels
Compared with C&N Europeans, the multivariate-adjusted odds ratio (95% CI) of having low HDL-C was significantly higher for Asian Indians, Mauritian Indians, Hong Kong Chinese, and Southern Europeans but lower for Qingdao Chinese, across all glucose categories from normal to diabetes (Table 2) . Asian Indians and Mauritian Indians tended to have higher odds ratios, but Southern Europeans had lower odds ratios for having high TG compared with the reference group. Unlike that for HDL-C or TG, the odds ratio for having high LDL-C was consistently lower in all Asian ethnic groups compared with the reference, across most of the glucose categories.
In contrast to the lower HDL-C and higher TG profiles, Asian Indians had considerably lower TC and LDL-C concentrations than others. As shown in Table 3 , 71% of nondiabetic and 57.6% of diabetic Asian Indians had low LDL-C (Ͻ3.0 mmol/liter), whereas the corresponding figures were 19.2 and 24.6% (P Ͻ 0.01) for C&N Europeans and 46.6 and 38.8% (P Ͻ 0.01) for Qingdao Chinese. However, even within the low LDL-C category, there was still a higher proportion of Asian Indians having low HDL-C compared with others ( Table 3) . The results were confirmed in the same analysis conducted separately for men and women (data not shown).
Discussion
This collaborative analysis of the data from the DECODE and the DECODA study cohorts showed considerable ethnic differences in lipid profiles within each glucose category. Asian Indians exhibited an adverse lipid pattern consisting of low HDL-C and high TG across all glucose categories as compared with other populations. Reduced HDL-C is prevalent even in Asian Indians with desirable LDL-C levels, regardless of the diabetic status. In addition, in most of the ethnic groups, individuals detected with undiagnosed diabetes had a worse lipid profile than did diagnosed cases.
The adverse lipid profiles associated with elevated glucose levels from normal to IFG and/or IGT and diabetes have been reported for both Europeans (1) and Asians (2) Model is adjusted for age, study cohort, BMI, systolic blood pressure, and smoking status.
a Reference group.
but the ethnic differences in lipid profiles given the same glucose levels have not been well investigated. In the HeartSCORE and IndiaSCORE studies (21) where lipids were measured with the same assay procedures for Asian Indians as for whites and blacks, Asian Indians had the lowest TC and HDL-C and highest TG among all the ethnic groups studied. In another multiethnic study of the 1992 Singapore National Health Survey (22) , Asian Indians appeared to have lower HDL-C but higher TG levels compared with Chinese. The findings of these previous studies are consistent with ours, although glucose status was not taken into account in the previous studies. The causes of ethnic difference in cardiovascular risk profile are complex. Possible contributors include genetic, environmental, psychosocial, cultural, and unmeasured factors, and many are not well clarified (23) . An adverse lipid profile in Asian Indians has been reported to be associated with the greater susceptibility to insulin resistance (4, 22, 24, 25) , and a higher percentage of body fat for the same BMI as compared with whites (26), which may contribute to the high prevalence of CVD (27) and diabetes (6, 28) in this ethnic group. In addition, it may also reflect the genetic variation, for example, at the apolipoprotein E locus (29) and an excess of other risk factors such as homocysteine, lipoprotein (a), or dietary fat (30).
To date, intensive control of dyslipidemia has been greatly emphasized in the prevention and management of CVD. Current guidelines from the National Cholesterol Education Program Adult Treatment Panel III (31), the European Society of Cardiology (20) , and the American Diabetes Association (32), mainly based on the data of whites, consistently recommend that LDL-C should be the primary target of therapy not only in patients with coronary heart disease or diabetes but also in persons with increased cardiovascular risk. Meanwhile, HDL-C has been either dropped from (20) or set as a secondary (32) or tertiary (31) target in the major guidelines despite the strong evidence of reduced HDL-C as an independent risk factor for CVD (33). This may change if more therapy choices developed to increase HDL-C levels and improve HDL function are shown to prevent CVD (34, 35). Our study showed that there are distinct patterns of lipid profiles between different ethnic groups. Considering the high proportion of Asian Indians with adverse HDL-C and TG profiles, appropriate approaches to increasing HDL-C may become an important treatment target in Asian Indians to reduce their excess CVD risks.
The difference in HDL-C concentrations between Qingdao and Hong Kong Chinese subgroups cannot be simply explained by the difference in assay methods. It may largely be attributed to the differences in dietary structure and preference, geographic, and environmental factors. Shellfish and beer, for example, are commonly consumed all year round in Qingdao. Nevertheless, whether other factors exist and contribute to the high HDL-C in Qingdao needs to be further investigated.
Similar to others (36, 37), we observed a worse lipid profile in individuals with undiagnosed diabetes than that of previously diagnosed patients in most of the ethnic groups, indicating that individuals with undiagnosed diabetes are at increased CVD risk and need to be identified and treated early. On the other hand, glycemic control is shown to be an important determinant of diabetic dyslipidemia (38). The better lipid profile in diagnosed diabetes as compared with undiagnosed diabetes might imply a benefit of lifestyle intervention or drug treatment targeting favorable metabolic profiles and hemoglobin A1c, a surrogate measure for average blood glucose. However, to what extent the levels of hemoglobin A1c have contributed to the differences is unknown due to the lack of information in the current study and in literature. In addition, the data on lipid-lowering treatment are not available for most of the earlier studies conducted in the 1990s because the statins were not widely prescribed at that time. These deserve further investigation in future studies.
In this collaborative analysis of large populations of European and Asian origins, all studies were populationbased with a random sampling approach except for the Hong Kong Workforce study and the Hisayama study (community-based). Populations of the same ethnicity were pooled to increase statistical power, and "study cohort" was also considered as a covariate in the data analysis. Although all blood samples for lipid assays were obtained in the fasting state (1, 10, 39), a limitation of this study was the lack of standardization in assay methods for lipids in different laboratories. This needs to be kept in mind when interpreting the results for, in particular, HDL-C, the measurement of which remains a major challenge over time. Except for the direct assays applied in a few of the studies, most of the studies have used chemical precipitation methods for HDL-C assays, including the heparin/Mn 2ϩ , the dextran sulfate MgCl 2 , the phosphotungstate MgCl 2 , and the polyethylene glycol method. The observed differences in HDL-C among ethnicities, to our knowledge, are less likely biased by the laboratory assays. First, there is a good agreement and a similar accuracy between the results of most of the precipitation methods (40). Second, the direct method and the precipitation method are shown to be closely correlated (41). On average, the HDL-C concentration obtained from the direct method is about 0.1-0.2 mmol/liter higher than that from the precipitation method when TG is less than 4.6 mmol/ liter (41, 42). The mean difference in the HDL-C concentration was about 0.4 -0.5 mmol/liter higher in Qingdao Chinese (direct or precipitation method) than in Asian Indians (precipitation method), much greater than what could be attributed to the difference in assay methods. Most importantly, our observation is consistent with previous reports regarding the adverse lipid profiles in Asian Indians compared with Western or Chinese populations where the lipids were measured using the same assay procedure for Indians as for others (21, 22) . Moreover, the mean lipid levels in our study were similar to others. The mean TC was 4.4 mmol/liter, HDL-C was 1.03-1.04 mmol/liter, and TG was 1.53-2.04 mmol/liter for Asian Indians in the HeartSCORE and IndiaSCORE study (21) and the Singapore National Health Survey (22) . This further strengthens the validity of the study.
In summary, there are distinct patterns of lipid profiles associated with ethnicity, regardless of the glucose levels. Ethnic-and region-specific considerations are an important component for guidelines on risk assessment and prevention of CVD.
